Non‐GAA Repeat Expansions in FGF14 Are Likely Not Pathogenic—Reply to: “Shaking Up Ataxia: FGF14 and RFC1 Repeat Expansions in Affected and …

…, M Synofzik, S Zuchner, B Brais, NA Başak… - Movement …, 2023 - Wiley Online Library
Nazlı A. Başak: design or conceptualization of the study, acquisition of data, analysis or
interpretation of data, drafting or revising the manuscript for intellectual content. Henry Houlden: …

NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

…, M Sendtner, A Ratti, JD Glass, JS Mora, NA Basak… - Nature …, 2016 - nature.com
To identify genetic factors contributing to amyotrophic lateral sclerosis (ALS), we conducted
whole-exome analyses of 1,022 index familial ALS (FALS) cases and 7,315 controls. In a …

Genetic variability in sporadic amyotrophic lateral sclerosis

…, M Povedano, PM Andersen, M Weber, NA Başak… - Brain, 2023 - academic.oup.com
With the advent of gene therapies for amyotrophic lateral sclerosis (ALS), there is a surge in
gene testing for this disease. Although there is ample experience with gene testing for …

[PDF][PDF] Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis

…, M Povedano, P Andersen, M Weber, NA Başak… - Neuron, 2022 - cell.com
Amyotrophic lateral sclerosis (ALS) is a complex disease that leads to motor neuron death.
Despite heritability estimates of 52%, genome-wide association studies (GWASs) have …

The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration

…, F Esselin, E de la Cruz, W Camu, NA Basak… - Nature …, 2022 - nature.com
Superoxide dismutase (SOD1) gene variants may cause amyotrophic lateral sclerosis, some
of which are associated with a distinct phenotype. Most studies assess limited variants or …

The Effect of SMN Gene Dosage on ALS Risk and Disease Severity

…, PM Andersen, M Weber, NA Başak… - Annals of …, 2021 - Wiley Online Library
Objective The role of the survival of motor neuron (SMN) gene in amyotrophic lateral sclerosis
(ALS) is unclear, with several conflicting reports. A decisive result on this topic is needed, …

[HTML][HTML] Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival

…, PM Andersen, M Weber, NA Başak… - Frontiers in cellular …, 2023 - frontiersin.org
Caveolin-1 and Caveolin-2 (CAV1 and CAV2) are proteins associated with intercellular
neurotrophic signalling. There is converging evidence that CAV1 and CAV2 (CAV1/2) genes …

Mutations in the tail and rod domains of the neurofilament heavy‐chain gene increase the risk of ALS

…, A Al Khleifat, PM Andersen, NA Başak… - Annals of Clinical …, 2024 - Wiley Online Library
Objective Neurofilament heavy‐chain gene (NEFH) variants are associated with multiple
neurodegenerative diseases, however, their relationship with ALS has not been robustly …

Phenotypic differences in a large family with Kennedy's disease from the Middle Black Sea region of Turkey

…, A Gundogdu, B Erdoğan, NA Başak - Amyotrophic Lateral …, 2010 - Taylor & Francis
We report the clinical and electrophysiological features of a large Turkish family with genetically
confirmed X-linked spinal and bulbar muscular atrophy (SBMA). Family members were …

Mutations in the tail domain of the neurofilament heavy chain gene increase the risk of amyotrophic lateral sclerosis

…, PM Andersen, NA Başak… - medRxiv, 2022 - medrxiv.org
Objective Genetic variation in the neurofilament heavy chain gene (NEFH) has been
convincingly linked to the pathogenesis of multiple neurodegenerative diseases, however, the …